Glycans in Diseases and Therapeutics

Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited.

  • Glycomedicine
  • Transfusion medicine
  • Congenital disorders of glycosylation (CDG)
  • Cancer biomarkers
  • Cardiovascular diseases
  • Cardiac arrest
  • Cancer associated coagulopathies

Related Conference of Glycans in Diseases and Therapeutics

October 10-11, 2022

International Conference on Biosimilars & Pharmaceuticals

Amsterdam, Netherlands
October 24-25, 2022

5th International Conference on Glycobiology

Paris, France
October 27-28, 2022

2nd Annual Summit on Advanced Bionics

Rome, Italy
November 14-15, 2022

4th International Conference on Biochemistry

London, UK
November 14-15, 2022

4th International Conference on Nucleic Acids

London, UK
February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in